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INTRODUCTION: Bone tissue engineering offers an 
alternative solution to the traditional bone substitutions 
e.g. autografts and allografts. This approach may help 
resolve the availability and donor site morbidity during 
autologous bone graft harvesting procedures and the 
risk of disease transmission with the use of allografts1. 
However, due to the poor mechanical and non-
osteoinductive properties of the currently available 
synthetic grafting materials such as ceramic and 
polymeric materials, the scaffolds with superior bone 
regeneration ability are required. Magnesium (Mg), as a 
potential additive, plays an essential role in skeletal 
development2. Our pervious study also showed that a 
specific amount of Mg ions is able to promote new bone 
formation3. Hence, our group has fabricated a hybrid 
porous scaffold made of polycaprolactone (PCL) and 
Mg micro-particles. This study aims to investigate the 
mechanical, in vitro and in vivo properties of the newly 
developed scaffold. 
EXPERIMENTAL METHODS: The Mg/PCL 
scaffolds were prepared by incorporating 4.8% 150μm 
Mg granules into PCL using salt leaching technique.  
Silane coupling agent (TMSPM) was coated on the Mg 
granules in order to enhance the bonding between PCL 
and Mg. Compression test was conducted to study the 
mechanical property of the scaffolds. A 7-day 
stimulated body fluid (SBF) immersion test was 
conducted to test their bioactivity. After that, the surface 
composition was checked by energy dispersive x-ray 
spectroscopy (EDS). The cytocompatibility of the 
scaffolds was studied by direct culture of green 
fluorescent protein mouse osteoblasts (GFPOB). 
Finally, the in vivo response of the scaffolds was 
evaluated by rat model for 3 months. Giemsa staining 
was used to visualize the new bone formation.  
RESULTS AND DISCUSSION: The compressive 
modulus of the Mg/PCL scaffold was doubled as 
compared to pure PCL scaffold, whereas increased 80% 
further after the TMSPM treatment (Figure 1). The 
result suggested the mechanical property of pure PCL 
scaffold could be significantly enhanced by 
incorporating Mg granules. The silane coupling 
treatment could further enhance its mechanical property. 
Calcium and phosphate deposition was detected on the 
hybrid scaffold but not on pure PCL scaffold after 7-day 
SBF immersion (data not shown). The apatite layer 
formation illustrated the enhancement of 
osteoconductivity of the PCL scaffold. Moreover, the 
hybrid scaffold was fully engulfed by living osteoblasts 
as compared to the pure PCL scaffold which indicated 
that the hybrid scaffold was able to enhance cell 
attachment and growth (Figure 2). This was possibly 
due to the effect of Mg ions release. In previous study, 
low level of Mg ions (i.e. 50ppm) was able to stimulate 
growth and differentiation of osteoblasts3. Hence, this 
explained why more new bone formation was able to  
 
grow inside the hybrid scaffold than pure PCL scaffold 
during animal implantation (Figure 3). The 
interconnected porous 
scaffolds would allow fluid flow, thereby enhancing 
bony tissue in-growth. All these favourable 
observations may attribute to the bioactivity 
enhancement due to the consistent release of Mg ions. 
However, the release of Mg ions should be controlled 
carefully since bone loss will be resulted if too much 
ions are released4.  
 
Figure 1 (Left) Compressive moduli of pure PCL and Mg/PCL hybrid 
scaffolds with and without TMSPM treatment. Significantly higher 
compressive moduli were found on the hybrid scaffolds than pure PCL 
scaffold. Figure 2 (Right) Microscopic view of the scaffolds after 3 
days GFP mouse osteoblasts culture. More living cells were found on 
the TMSPM-treated Mg/PCL scaffold as compared to the pure PCL 
scaffold. 
 Figure 3.  Giemsa stained histological photographs after 3 months of 
implantation. More newly formed bone was found within the hybrid 
scaffold as compared to the pure PCL scaffold.  
CONCLUSION: This study demonstrates that the 
newly developed Mg/PCL scaffolds are able to enhance 
the mechanical property and inferior bioactivity of pure 
PCL scaffold so as to encourage bone formation and in-
growth. TMSPM silane-coupling treatment can further 
enhance the mechanical property of the scaffolds. 
Hence, all these promising results have shown that the 
modified Mg/PCL hybrid porous scaffolds can be 
potentially applied in large bone defect fixation. 
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